Goals · Specialty & Clinical
Hair loss, skin aging, acne, and pigmentation. Cosmetic and regenerative targets.
Compounds linked to this goal in the catalogue, ordered by role — primary, then support, then optional. Click any card for the full mechanism, dosing, and evidence.
Hair Growth Copper Peptide | Dermal Papilla Stimulator
Half-life: Not established
Bioregulatory Tripeptide | Cartilage & Connective Tissue Support
Half-life: Minutes (short peptide); effects persist via epigenetic changes
Copper Peptide | Skin Regeneration & Anti-Aging Compound
Half-life: 0.5-2 hours
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
Half-life: 1-2 hours
Human Cathelicidin | Antimicrobial Peptide
Half-life: Short (rapid proteolytic degradation)
Melanocortin Receptor Agonist
Half-life: ~30 minutes
Synthetic Melanocortin Peptide | Tanning & Sexual Function
Half-life: ~2 hours
Acetyl Octapeptide-3 | Anti-Wrinkle & Expression Line Peptide
Half-life: Not established (primarily topical use)
No SARMs tagged for this goal yet.
Topical Androgen Receptor Inhibitor | Acne & Hair Loss
Half-life: Short topical (local action; rapidly metabolized to cortexolone)
Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH
Half-life: ~5 weeks (extremely long; active metabolite accumulation over months)
5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH
Half-life: 6-8 hours (DHT suppression persists ~24 hours)
Antifungal | Topical Anti-Androgen for Hair Loss
Half-life: Topical application stays local with minimal systemic absorption
Vasodilator | Hair Growth Stimulation
Half-life: ~4 hours (oral); topical effects persist significantly longer due to local tissue retention
MPC Inhibitor | Hair Follicle Stem Cell Activation
Half-life: Topical application; exact pharmacokinetics not published
Topical Anti-Androgen | Experimental Hair Loss Treatment
Half-life: ~1 hour topically (very short systemic half-life)
Retinoid | Skin Rejuvenation & Anti-Aging
Half-life: 0.5-2 hours (topical, local skin metabolism)